MeSH term
Frequency | Condition_Probility | Animals | 10 | 0.0 |
Benzopyrans/pharmacology | 2 | 8.0 |
Cell Line | 4 | 0.0 |
Humans | 30 | 0.0 |
Immunoblotting | 2 | 0.0 |
In Vitro | 2 | 0.0 |
Patch-Clamp Techniques | 6 | 1.0 |
Piperidines/pharmacology | 2 | 3.0 |
Potassium/metabolism | 3 | 2.0 |
*Potassium Channels, Voltage-Gated | 22 | 8.0 |
Research Support, Non-U.S. Gov't | 24 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 12 | 0.0 |
Adult | 13 | 0.0 |
Aged | 7 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
DNA Mutational Analysis | 7 | 0.0 |
Electrocardiography | 9 | 2.0 |
Family Health | 4 | 0.0 |
Follow-Up Studies | 2 | 0.0 |
Genetic Predisposition to Disease/genetics | 3 | 0.0 |
Genotype | 5 | 0.0 |
Long QT Syndrome/*genetics | 11 | 28.0 |
Male | 18 | 0.0 |
Middle Aged | 8 | 0.0 |
Mutation/*genetics | 3 | 0.0 |
Pedigree | 8 | 0.0 |
Phenotype | 10 | 0.0 |
Potassium Channels/genetics | 5 | 10.0 |
Female | 16 | 0.0 |
*Mutation | 8 | 0.0 |
Mutation, Missense | 4 | 0.0 |
Polymorphism, Single-Stranded Conformational | 6 | 0.0 |
Potassium Channels/*genetics | 9 | 6.0 |
Sodium Channels/*genetics | 3 | 3.0 |
*Cation Transport Proteins | 15 | 6.0 |
*DNA-Binding Proteins | 13 | 0.0 |
Mice | 2 | 0.0 |
Potassium Channels/*genetics/*metabolism | 2 | 18.0 |
*Trans-Activators | 13 | 2.0 |
Reproducibility of Results | 2 | 0.0 |
Gene Expression | 3 | 0.0 |
Mutation | 5 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Adolescent | 7 | 0.0 |
Adrenergic beta-Antagonists/*therapeutic use | 2 | 5.0 |
Child | 4 | 0.0 |
Long QT Syndrome/*drug therapy/*genetics | 2 | 100.0 |
Treatment Outcome | 2 | 0.0 |
COS Cells | 3 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Genes, Dominant | 2 | 0.0 |
Alleles | 2 | 0.0 |
Asian Continental Ancestry Group | 2 | 0.0 |
Base Sequence | 5 | 0.0 |
China | 3 | 0.0 |
Electrophysiology | 3 | 0.0 |
European Continental Ancestry Group | 2 | 0.0 |
*Genetic Screening | 2 | 1.0 |
Molecular Sequence Data | 5 | 0.0 |
Mutagenesis, Site-Directed | 4 | 0.0 |
*Polymorphism, Genetic | 3 | 0.0 |
Potassium Channels, Voltage-Gated/*genetics | 3 | 37.0 |
Transfection | 2 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Electric Conductivity | 2 | 1.0 |
Potassium Channels/*genetics/metabolism | 3 | 10.0 |
Syndrome | 2 | 0.0 |
Comparative Study | 3 | 0.0 |
Infant | 4 | 0.0 |
Long QT Syndrome/genetics/physiopathology | 3 | 60.0 |
Chromatography, High Pressure Liquid/*methods | 2 | 1.0 |
Heterozygote | 2 | 0.0 |
Nucleic Acid Denaturation | 2 | 2.0 |
Child, Preschool | 3 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Long QT Syndrome/*genetics/physiopathology | 2 | 25.0 |